Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5823271, 9 pages
http://dx.doi.org/10.1155/2016/5823271
Research Article

Oxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity

1Department of Clinical Pathomorphology, Medical University, Jaczewskiego 8, 20-950 Lublin, Poland
2Department of Gastroenterology with Endoscopic Unit, Medical University, Jaczewskiego 8, 20-950 Lublin, Poland

Received 18 March 2016; Revised 24 April 2016; Accepted 3 May 2016

Academic Editor: Minjun Chen

Copyright © 2016 Agnieszka Korolczuk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. D. Kahan, “Cyclosporine: a revolution in transplantation,” Transplantation Proceedings, vol. 31, no. 1-2, pp. 14S–15S, 1999. View at Google Scholar · View at Scopus
  2. D. Tedesco and L. Haragsim, “Cyclosporine: a review,” Journal of Transplantation, vol. 2012, Article ID 230386, 7 pages, 2012. View at Publisher · View at Google Scholar
  3. C. Ponticelli, “Cyclosporine: from renal transplantation to autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1051, pp. 551–558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Colombo, N. Cassano, G. Altomare, A. Giannetti, and G. A. Vena, “Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 4, pp. 1143–1152, 2010. View at Google Scholar · View at Scopus
  5. S. Khattri, A. Shemer, M. Rozenblit et al., “Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology,” Journal of Allergy and Clinical Immunology, vol. 133, no. 6, pp. 1626–1634, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. N. J. Serkova, U. Christians, and L. Z. Benet, “Biochemical mechanisms of cyclosporine neurotoxicity,” Molecular Interventions, vol. 4, no. 2, pp. 97–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Abboud and N. Kaplowitz, “Drug-induced liver injury,” Drug Safety, vol. 30, no. 4, pp. 277–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. I. Lorber, C. T. van Buren, S. M. Flechner, C. Williams, and B. D. Kahan, “Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients,” Transplantation, vol. 43, no. 1, pp. 35–40, 1987. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Hillebrand, L. A. Castro, and R. Habersetzer, “Chronic cyclosporine hepatotoxicity after renal transplantation,” Transplantation Proceedings, vol. 18, no. 5, pp. 1020–1022, 1986. View at Google Scholar · View at Scopus
  10. M. Battino, S. Bompadre, L. Leone et al., “The effect of Cyclosporine A chronic administration on the antioxidant pattern of rat liver mitochondria: structural and functional consequences,” BioFactors, vol. 18, no. 1–4, pp. 271–275, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kurus, M. Esrefoglu, G. Sogutlu, and A. Atasever, “Melatonin prevents cyclosporine-induced hepatotoxicity in rats,” Medical Principles and Practice, vol. 18, no. 5, pp. 407–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Akbulut, H. Elbe, C. Eris et al., “Effects of antioxidant agents against cyclosporine-induced hepatotoxicity,” Journal of Surgical Research, vol. 193, no. 2, pp. 658–666, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Zhi, X. Li, S. Yamashina et al., “Cyclosporin a causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine,” Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 3, pp. 858–865, 2001. View at Google Scholar · View at Scopus
  14. M. Kadmon, C. Klünemann, M. Böhme et al., “Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile,” Gastroenterology, vol. 104, no. 5, pp. 1507–1514, 1993. View at Google Scholar · View at Scopus
  15. M. Böhme, G. Jedlitschky, I. Leier, M. Büchler, and D. Keppler, “ATP-dependent export pumps and their inhibition by cyclosporins,” Advances in Enzyme Regulation, vol. 34, pp. 371–380, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. Kwak and K. C. Mun, “The beneficial effect of melatonin for cyclosporine hepatotoxicity in rats,” Transplantation Proceedings, vol. 32, no. 7, pp. 2009–2010, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Rezzani, L. Rodella, B. Buffoli et al., “Change in renal heme oxygenase expression in cyclosporine A-induced injury,” Journal of Histochemistry and Cytochemistry, vol. 53, no. 1, pp. 105–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Florio, R. Ciarcia, L. Crispino et al., “Hydrocortisone has a protective effect on Cyclosporin A-induced cardiotoxicity,” Journal of Cellular Physiology, vol. 195, no. 1, pp. 21–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Türk, M. Sönmez, A. O. Çeribaşi, A. Yüce, and A. Ateşşahin, “Attenuation of cyclosporine A-induced testicular and spermatozoal damages associated with oxidative stress by ellagic acid,” International Immunopharmacology, vol. 10, no. 2, pp. 177–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. U. Ebru, U. Burak, S. Yusuf et al., “Cardioprotective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats,” Basic and Clinical Pharmacology and Toxicology, vol. 103, no. 6, pp. 574–580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Özkan, S. Ulusoy, M. Alkanat et al., “Antiapoptotic and antioxidant effects of GSPE in preventing cyclosporine A-induced cardiotoxicity,” Renal Failure, vol. 34, no. 4, pp. 460–466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. I. Galán, M. E. Muñoz, and R. Jiménez, “S-adenosylmethionine protects against cyclosporin A-induced alterations in rat liver plasma membrane fluidity and functions,” Journal of Pharmacology and Experimental Therapeutics, vol. 290, no. 2, pp. 774–781, 1999. View at Google Scholar · View at Scopus
  23. H. H. Hagar, “The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats,” Toxicology Letters, vol. 151, no. 2, pp. 335–343, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kurus, M. Esrefoglu, A. B. Karabulut, G. Sogutlu, M. Kaya, and A. Otlu, “Oral l-arginine protects against cyclosporine-induced hepatotoxicity in rats,” Experimental and Toxicologic Pathology, vol. 60, no. 4-5, pp. 411–419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Pari and R. Sivasankari, “Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats,” Fundamental and Clinical Pharmacology, vol. 22, no. 4, pp. 395–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Erarslan, F. Ekiz, B. Uz et al., “Effects of erdosteine on cyclosporine-A–induced hepatotoxicity in rats,” Drug and Chemical Toxicology, vol. 34, no. 1, pp. 32–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Ş. R. Erdem, S. Emre-Aydingöz, P. Atilla et al., “Cyclosporine A-induced acute hepatotoxicity in guinea pigs is associated with endothelin-mediated decrease in local hepatic blood flow,” Life Sciences, vol. 88, no. 17-18, pp. 753–760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Kaplowitz, “Drug-induced liver injury,” Clinical Infectious Diseases, vol. 38, supplement 2, pp. S44–S48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. U. A. Boelsterli, H. K. Ho, S. Zhou, and K. Y. Leow, “Bioactivation and hepatotoxicity of nitroaromatic drugs,” Current Drug Metabolism, vol. 7, no. 7, pp. 715–727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Yamazaki, M. Miyake, H. Sato et al., “Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats,” Toxicology and Applied Pharmacology, vol. 268, no. 1, pp. 79–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Russmann, G. A. Kullak-Ublick, and I. Grattagliano, “Current concepts of mechanisms in drug-induced hepatotoxicity,” Current Medicinal Chemistry, vol. 16, no. 23, pp. 3041–3053, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Grattagliano, L. Bonfrate, C. V. Diogo, H. H. Wang, D. Q. H. Wang, and P. Portincasa, “Biochemical mechanisms in drug-induced liver injury: certainties and doubts,” World Journal of Gastroenterology, vol. 15, no. 39, pp. 4865–4876, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Sgro, F. Clinard, K. Ouazir et al., “Incidence of drug-induced hepatic injuries: a French population-based study,” Hepatology, vol. 36, no. 2, pp. 451–455, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. R. J. Andrade, M. I. Lucena, M. C. Fernández et al., “Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period,” Gastroenterology, vol. 129, no. 2, pp. 512–521, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. G. E. N. Kass, “Mitochondrial involvement in drug-induced hepatic injury,” Chemico-Biological Interactions, vol. 163, no. 1-2, pp. 145–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Krähenbühl, “Mitochondria: important target for drug toxicity?” Journal of Hepatology, vol. 34, no. 2, pp. 334–336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Labbe, D. Pessayre, and B. Fromenty, “Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies,” Fundamental and Clinical Pharmacology, vol. 22, no. 4, pp. 335–353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Tanikawa and T. Torimura, “Studies on oxidative stress in liver diseases: important future trends in liver research,” Medical Molecular Morphology, vol. 39, no. 1, pp. 22–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Zhu, Y. Wang, L. Zhang, and Q. Guo, “Oxidative stress and liver disease,” Hepatology Research, vol. 42, no. 8, pp. 741–749, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Yüce, A. Ateşşahin, and A. O. Çeribaşi, “Amelioration of cyclosporine A-induced renal, hepatic and cardiac damages by ellagic acid in rats,” Basic and Clinical Pharmacology and Toxicology, vol. 103, no. 2, pp. 186–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Uz, B. Uz, A. Kaya et al., “Protective effect of erdosteine on cyclosporine induced chronic nephrotoxicity in rats,” Nephro-Urology Monthly, vol. 3, no. 4, pp. 280–284, 2011. View at Google Scholar · View at Scopus
  42. G. Suleymanlar, I. Suleymanlar, J. I. Shapiro, and L. Chan, “Possible role of lipid peroxidation in cyclosporine nephrotoxicity in rats,” Transplantation Proceedings, vol. 26, no. 5, pp. 2888–2889, 1994. View at Google Scholar · View at Scopus
  43. N. A. Bobadilla, G. Gamba, E. Tapia et al., “Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression,” American Journal of Physiology: Renal Physiology, vol. 274, no. 4, pp. F791–F798, 1998. View at Google Scholar · View at Scopus
  44. M. J. Mihatsch, M. Kyo, K. Morozumi, Y. Yamaguchi, V. Nickeleit, and B. Ryffel, “The side-effects of ciclosporine-A and tacrolimus,” Clinical Nephrology, vol. 49, no. 6, pp. 356–363, 1998. View at Google Scholar · View at Scopus
  45. M. Nishida, H. Ogawa, M. Tamai, K. Ishiwari, and K. Hamaoka, “Role of hydrogen peroxide in cyclosporine-induced renal tubular cell (LLC-PK1) injury,” Journal Pharmacological Sciences, vol. 91, no. 3, pp. 255–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Y. Han, K. C. Mun, H. J. Choi et al., “Effects of cyclosporine and tacrolimus on the oxidative stress in cultured mesangial cells,” Transplantation Proceedings, vol. 38, no. 7, pp. 2240–2241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Wolf, C.-F. Trendelenburg, C. Diez-Fernandez et al., “Cyclosporine A-induced oxidative stress in rat hepatocytes,” The Journal of Pharmacology and Experimental Therapeutics, vol. 280, no. 3, pp. 1328–1334, 1997. View at Google Scholar · View at Scopus
  48. S. H. Jeon, Y. J. Piao, K. J. Choi et al., “Prednisolone suppresses cyclosporin A-induced apoptosis but not cell cycle arrest in MDCK cells,” Archives of Biochemistry and Biophysics, vol. 435, no. 2, pp. 382–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Jennings, C. Koppelstaetter, S. Aydin et al., “Cyclosporine A induces senescence in renal tubular epithelial cells,” American Journal of Physiology—Renal Physiology, vol. 293, no. 3, pp. F831–F838, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. E. A. Burdmann, T. F. Andoh, L. Yu, and W. M. Bennett, “Cyclosporine nephrotoxicity,” Seminars in Nephrology, vol. 23, no. 5, pp. 465–476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Tariq, C. Morais, S. Sobki, M. Al Sulaiman, and A. Al Khader, “N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats,” Nephrology Dialysis Transplantation, vol. 14, no. 4, pp. 923–929, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Amudha, A. Josephine, and P. Varalakshmi, “Role of lipoic acid in reducing the oxidative stress induced by cyclosporine A,” Clinica Chimica Acta, vol. 372, no. 1-2, pp. 134–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Ay, G. Uzun, Y. Onem et al., “Effect of hyperbaric oxygen on cyclosporine-induced nephrotoxicity and oxidative stress in rats,” Renal Failure, vol. 29, no. 4, pp. 495–501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. I. Durak, M. Kaçmaz, M. Y. Burak Çimen, S. Büyükkoçak, S. Elgün, and H. S. Öztürk, “The effects of cyclosporine on antioxidant enzyme activities and malondialdehyde levels in rabbit hepatic tissues,” Transplant Immunology, vol. 10, no. 4, pp. 255–258, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Selcoki, E. Uz, R. Bayrak et al., “The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats,” Toxicology, vol. 239, no. 1-2, pp. 53–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. K. M. Humphries, Y. Yoo, and L. I. Szweda, “Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal,” Biochemistry, vol. 37, no. 2, pp. 552–557, 1998. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Ying, “NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences,” Antioxidants and Redox Signaling, vol. 10, no. 2, pp. 179–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. J. P. De Hornedo, G. De Arriba, M. Calvino, S. Benito, and T. Parra Cid, “Cyclosporin A causes oxidative stress and mitochondrial dysfunction in renal tubular cells,” Nefrologia, vol. 27, no. 5, pp. 565–573, 2007. View at Google Scholar · View at Scopus
  59. A. Wolf, S. Grub, and E. Persohn, “In vitro induction of apoptosis in rat hepatocytes by cyclosporine A,” Anales de la Real Academia de Farmacia, vol. 66, no. 4, 2000. View at Google Scholar
  60. Q.-F. Liu, Z.-Y. Deng, J.-M. Ye, A.-L. He, and S.-S. Li, “Ginsenoside Rg1 protects chronic cyclosporin A nephropathy from tubular cell apoptosis by inhibiting endoplasmic reticulum stress in rats,” Transplantation Proceedings, vol. 47, no. 2, pp. 566–569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. E. A. Slee, C. Adrain, and S. J. Martin, “Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis,” Journal of Biological Chemistry, vol. 276, no. 10, pp. 7320–7326, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Grub, E. Persohn, W. E. Trommer, and A. Wolf, “Mechanisms of cyclosporine A-induced apoptosis in rat hepatocyte primary cultures,” Toxicology and Applied Pharmacology, vol. 163, no. 3, pp. 209–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. M. L. Circu and T. Y. Aw, “Reactive oxygen species, cellular redox systems, and apoptosis,” Free Radical Biology and Medicine, vol. 48, no. 6, pp. 749–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Justo, C. Lorz, A. Sanz, J. Egido, and A. Ortiz, “Intracellular mechanisms of cyclosporin A–induced tubular cell apoptosis,” Journal of the American Society of Nephrology, vol. 14, no. 12, pp. 3072–3080, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. M. K. Roy, M. Takenaka, M. Kobori, K. Nakahara, S. Isobe, and T. Tsushida, “Apoptosis, necrosis and cell proliferation-inhibition by cyclosporine A in U937 cells (a human monocytic cell line),” Pharmacological Research, vol. 53, no. 3, pp. 293–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. İ. Durak, H. Özbek, and S. Elgün, “Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants,” International Immunopharmacology, vol. 4, no. 3, pp. 469–473, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. A. M. Mohamadin, H. A. El-Beshbishy, and M. A. El-Mahdy, “Green tea extract attenuates cyclosporine A-induced oxidative stress in rats,” Pharmacological Research, vol. 51, no. 1, pp. 51–57, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Kaya, A. Koc, S. Sogut et al., “The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats,” Journal of Applied Toxicology, vol. 28, no. 1, pp. 15–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Andrés and M. Cascales, “Novel mechanism of Vitamin E protection against cyclosporine A cytotoxicity in cultured rat hepatocytes,” Biochemical Pharmacology, vol. 64, no. 2, pp. 267–276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Orrenius, V. Gogvadze, and B. Zhivotovsky, “Mitochondrial oxidative stress: implications for cell death,” Annual Review of Pharmacology and Toxicology, vol. 47, pp. 143–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Otera and K. Mihara, “Mitochondrial dynamics: functional link with apoptosis,” International Journal of Cell Biology, vol. 2012, Article ID 821676, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. J. A. Dykens, J. D. Jamieson, L. D. Marroquin et al., “In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone,” Toxicological Sciences, vol. 103, no. 2, pp. 335–345, 2008. View at Publisher · View at Google Scholar · View at Scopus